China has been engaged in the R&D and manufacturing of semi-automatic coagulation analyzers for over a decade, and based on the data from the website of the NMPA, in 2024 and 2025 (as od 15 August), a total of 2 instruments from 2 manufacturers have obtained registration certificates...

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China. Latest news

Molecular diagnostic company Canary Global announced on Tuesday that it received CE marking last week for its DigiGene COVID-19 Rapid Molecular Test Kit.

Today, the Top Employers Institute released the Top Employers China 2022 list of certified organizations. Danaher, Roche, Abbott, Ortho, Biomeier, BD and other companies have won the "Top Employers China 2022" certification.

Sema4 said Tuesday that it will acquire GeneDx from Opko Health for approximately $623 million in cash, stock consideration, and milestone payments.

The Hurun Research Institute today released the Hurun China 500 Most Valuable Private Companies 2021, a list of the Top 500 China non-state-controlled enterprises ranked according to their value.

Threads or earphone cables placed in tight spaces get easily tangled. On the contrary, our body's long and loose DNA packs into rod-shaped chromosomes one-millionth its size when the cell divides.

A new study led by researchers at Harvard Medical School has identified a set of cellular receptors for at least three related alphaviruses shared across mosquitoes, humans, and animals that host these viruses.

Wuhan Thalys Biotechnology Co.,Ltd. ("Thalys") announced that it has signed a contract with Norwegian high-tech molecular diagnostic company Genetic Analysis ("GA") for the laboratory self-built project testing (LDT) for the Chinese market.

Specific nuclear proteins act as a glue to pack genetic material in an absurdly small space in the human body. Proteins “gluing” DNA are called linker histones, and hold their secret in their electric charge. They are strongly positively charged, fusing to the strongly negatively charged DNA.

Expects Q4 2021 revenue of $29-31 million; Full year 2021 revenue of $109-111 million

ISB-led study shows unvaccinated pregnant people with COVID-19 are more likely to have poor birth outcomes even if they did not experience severe respiratory problems during infection.